JP2025530888A5 - - Google Patents
Info
- Publication number
- JP2025530888A5 JP2025530888A5 JP2024573474A JP2024573474A JP2025530888A5 JP 2025530888 A5 JP2025530888 A5 JP 2025530888A5 JP 2024573474 A JP2024573474 A JP 2024573474A JP 2024573474 A JP2024573474 A JP 2024573474A JP 2025530888 A5 JP2025530888 A5 JP 2025530888A5
- Authority
- JP
- Japan
- Prior art keywords
- isvd
- amino acid
- seq
- optionally
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22305869 | 2022-06-14 | ||
| EP22305869.4 | 2022-06-14 | ||
| PCT/EP2023/065925 WO2023242247A1 (en) | 2022-06-14 | 2023-06-14 | Immunoglobulin single variable domains targeting t cell receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025530888A JP2025530888A (ja) | 2025-09-18 |
| JP2025530888A5 true JP2025530888A5 (enExample) | 2026-04-22 |
Family
ID=82404277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024573474A Pending JP2025530888A (ja) | 2022-06-14 | 2023-06-14 | Ｔ細胞レセプターを標的とするイムノグロブリン単一可変ドメイン |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240109965A1 (enExample) |
| EP (1) | EP4540286A1 (enExample) |
| JP (1) | JP2025530888A (enExample) |
| KR (1) | KR20250023503A (enExample) |
| CN (1) | CN119630705A (enExample) |
| AR (1) | AR129614A1 (enExample) |
| AU (1) | AU2023290487A1 (enExample) |
| CA (1) | CA3259417A1 (enExample) |
| CO (1) | CO2025000062A2 (enExample) |
| IL (1) | IL317588A (enExample) |
| MX (1) | MX2024015501A (enExample) |
| TW (1) | TW202415678A (enExample) |
| WO (1) | WO2023242247A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20260068087A (ko) * | 2023-09-04 | 2026-05-13 | 사노피 | 글리피칸-3-발현 종양의 치료에 사용하기 위한 폴리펩티드 |
| WO2026052756A1 (en) | 2024-09-05 | 2026-03-12 | Ablynx Nv | Her2 binding immunoglobulin single variable domains, constructs comprising the same and uses thereof |
| WO2026078159A1 (en) | 2024-10-10 | 2026-04-16 | Ablynx Nv | Immune cell engagers and methods comprising the same |
| WO2026132542A2 (en) * | 2024-12-20 | 2026-06-25 | Ablynx Nv | Immunoglobulin single variable domains targeting pd-1 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69334275D1 (de) | 1992-08-21 | 2009-05-20 | Univ Bruxelles | Immunoglobuline ohne Leichtkette |
| EP0739981A1 (en) | 1995-04-25 | 1996-10-30 | Vrije Universiteit Brussel | Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes |
| DK1027439T3 (da) | 1997-10-27 | 2010-05-10 | Bac Ip Bv | Multivalente antigenbindende proteiner |
| CA2326389C (en) | 1998-04-21 | 2007-01-23 | Micromet Gesellschaft Fur Biomedizinische Forschung Mbh | Novel cd19xcd3 specific polypeptides and uses thereof |
| AU2002362197A1 (en) * | 2001-12-28 | 2003-07-24 | Chugai Seiyaku Kabushiki Kaisha | Method of stabilizing protein |
| NZ540194A (en) | 2002-11-08 | 2008-07-31 | Ablynx Nv | Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| AU2006249144B2 (en) | 2005-05-18 | 2011-11-17 | Ablynx Nv | Improved NanobodiesTM against Tumor Necrosis Factor-alpha |
| US8236308B2 (en) | 2005-10-11 | 2012-08-07 | Micromet Ag | Composition comprising cross-species-specific antibodies and uses thereof |
| AU2007237501A1 (en) | 2006-04-14 | 2007-10-25 | Ablynx N.V. | DP-78-like nanobodies |
| JP2010500876A (ja) | 2006-08-18 | 2010-01-14 | アブリンクス エン．ヴェー． | Ｉｌ−６媒介性シグナル伝達に関連する疾患及び障害の治療のための、ｉｌ−６ｒに指向性を有するアミノ酸配列及びこれを含むポリペプチド |
| LT3466972T (lt) | 2011-06-23 | 2026-06-25 | Ablynx Nv | Serumo albuminą surišantys baltymai |
| CA3141978A1 (en) | 2011-06-23 | 2012-12-27 | Ablynx Nv | Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains |
| LT3248986T (lt) | 2014-05-16 | 2022-03-25 | Ablynx Nv | Imunoglobulino kintami domenai |
| IL254039B2 (en) * | 2015-02-19 | 2023-12-01 | Compugen Ltd | Anti-pvrig antibodies and methods of use |
| HRP20191800T1 (hr) | 2015-05-13 | 2019-12-27 | Ablynx N.V. | Polipeptidi koji regrutiraju t stanice koji se temelje na tcr alfa/beta reaktivnosti |
| HUE057241T2 (hu) | 2015-11-13 | 2022-04-28 | Ablynx Nv | Javított, szérumalbumint kötõ immunoglobulin variábilis domének |
| AU2016357460B2 (en) | 2015-11-18 | 2023-07-27 | Ablynx Nv | Improved serum albumin binders |
| US11840569B2 (en) | 2016-11-16 | 2023-12-12 | Ablynx N.V. | T cell recruiting polypeptides capable of binding CD123 and TCR alpha/beta |
| WO2018104444A1 (en) | 2016-12-07 | 2018-06-14 | Ablynx Nv | Improved serum albumin binding immunoglobulin single variable domains |
| EP4442709A3 (en) | 2017-01-17 | 2024-12-25 | Ablynx NV | Improved serum albumin binders |
| EP3571224B1 (en) | 2017-01-17 | 2024-08-07 | Ablynx NV | Improved serum albumin binders |
| PH12023500013A1 (en) * | 2020-12-04 | 2024-03-11 | Tidal Therapeutics Inc | Ionizable cationic lipids and lipi nanoparticles, and methods of synthesis and use thereof |
| CA3205422A1 (en) * | 2020-12-18 | 2022-06-23 | Ablynx Nv | Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and t cell receptor |
| WO2022129637A1 (en) * | 2020-12-18 | 2022-06-23 | Ablynx Nv | T cell recruiting polypeptides based on tcr alpha/beta reactivity |
-
2023
- 2023-06-14 CN CN202380057045.XA patent/CN119630705A/zh active Pending
- 2023-06-14 JP JP2024573474A patent/JP2025530888A/ja active Pending
- 2023-06-14 AU AU2023290487A patent/AU2023290487A1/en active Pending
- 2023-06-14 TW TW112122236A patent/TW202415678A/zh unknown
- 2023-06-14 CA CA3259417A patent/CA3259417A1/en active Pending
- 2023-06-14 WO PCT/EP2023/065925 patent/WO2023242247A1/en not_active Ceased
- 2023-06-14 KR KR1020257000924A patent/KR20250023503A/ko active Pending
- 2023-06-14 AR ARP230101523A patent/AR129614A1/es unknown
- 2023-06-14 IL IL317588A patent/IL317588A/en unknown
- 2023-06-14 EP EP23732562.6A patent/EP4540286A1/en active Pending
- 2023-06-14 US US18/334,642 patent/US20240109965A1/en active Pending
-
2024
- 2024-12-13 MX MX2024015501A patent/MX2024015501A/es unknown
-
2025
- 2025-01-07 CO CONC2025/0000062A patent/CO2025000062A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108250296B (zh) | 全人源抗人pd-l1单克隆抗体及其应用 | |
| JP2022512653A5 (enExample) | ||
| JP2022061992A5 (enExample) | ||
| JP2020500510A5 (enExample) | ||
| TWI671315B (zh) | 具有交叉結合區定向之雙重可變區類抗體結合蛋白 | |
| ES2199941T3 (es) | Anticuerpos monoclonales contra el receptor de la interferona, con actividad neutralizadora contra el interferon de tipo j. | |
| JP2021102633A5 (enExample) | ||
| JP7663977B2 (ja) | 抗ｐｄ―ｌ１抗体およびその用途 | |
| JP2018537421A5 (enExample) | ||
| JP2020048564A5 (enExample) | ||
| JP2019151634A5 (enExample) | ||
| EP2050764A1 (en) | Novel polyvalent bispecific antibody format and uses thereof | |
| JP2021530236A5 (enExample) | ||
| JP2021524267A5 (enExample) | ||
| JP2023505492A5 (enExample) | ||
| JP2012501670A5 (enExample) | ||
| WO2016197497A1 (zh) | 一种抗pd-1的单克隆抗体及其获得方法 | |
| JP2018526981A5 (enExample) | ||
| JP2023553694A5 (enExample) | ||
| JP2009502171A5 (enExample) | ||
| JP2015519375A5 (enExample) | ||
| JP2017529067A5 (enExample) | ||
| JP2011509245A5 (enExample) | ||
| MX2010013239A (es) | Inmunoglobulinas de dominio variable doble y usos de las mismas. | |
| JP2021521793A5 (enExample) |